| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 17.3× | −1.7× | |
| Price / Book | 6.6× | 2.0× | |
| Price / Sales | 2.5× | 4.0× | |
| Price / Free cash flow | 9.5× | −1.6× | |
| EV / EBITDA | 10.4× | −1.2× | |
| Earnings yield | 5.8% | −14.6% | |
| Free cash flow yield | 10.5% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.49 | −0.76% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $251.95 | −1.41% | $607.17B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.16 | −0.79% | $500.38B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.04 | +0.15% | $360.87B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.72 | −0.84% | $357.05B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.19 | −0.29% | $277.84B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.04 | −0.23% | $255.95B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.01 | −1.88% | $250.32B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $426.99 | −1.27% | $230.84B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.47 | −1.10% | $191.54B | 22.8× | 37.5% | +32.0% |
